Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
The 3 Leaders of the Gene Editing Revolution
04:12pm, Friday, 08'th Jul 2022
There's a wide field of gene editing stocks, but if you're looking for the best opportunities, there are a few likely winners to watch. The post The 3 Leaders of the Gene Editing Revolution appeared f
7 Moonshot Investments Upending a $10 Trillion Industry
03:53pm, Friday, 08'th Jul 2022
Gene editing is expensive at an estimated $5 billion per drug, but it could change the world in the very near future. The post 7 Moonshot Investments Upending a $10 Trillion Industry appeared first on
This Hot Growth Stock Is Still a Buy After Enormous Gains
06:15am, Friday, 08'th Jul 2022
This biotech stock is worth holding onto for a while.
Want to Beat the Bear Market? Try These 2 Stocks
06:00am, Friday, 08'th Jul 2022
There's plenty of growth ahead for these companies.
Vertex (VRTX) VX-880 Early Study Sees Lifting of Clinical Hold
12:26pm, Wednesday, 06'th Jul 2022
The FDA lifts clinical hold on Vertex's (VRTX) study on VX-880, its stem-cell-derived, fully differentiated islet replacement therapy that could offer a functional cure for type 1 diabetes patients.
3 Unstoppable Growth Stocks To Buy in 2022 and Beyond
07:02am, Wednesday, 06'th Jul 2022
They're weathering the bear market better than many.
2 Reasons to Buy Vertex Pharmaceuticals Now
06:00am, Tuesday, 05'th Jul 2022
The stock gained momentum in the first half.
3 Stocks You Can Buy and Hold for Decades
05:57am, Saturday, 02'nd Jul 2022
These companies are built to last.
The Best Biotech Stock on the Market Right Now
05:52am, Wednesday, 29'th Jun 2022
It's not a close contest.
5 High-Performing Cathie Wood Stocks as of June
06:06pm, Tuesday, 28'th Jun 2022
As investors continue grappling with a volatile stock market, five stocks in Catherine Wood (Trades, Portfolio)'s first-quarter 13F equity portfolio that have high GF Scores and have outperformed the
Vertex: In A Class By Itself, Promising Pipeline Of Game-Changing Drugs
02:27pm, Tuesday, 28'th Jun 2022
Vertex Pharma develops, manufactures, and commercializes small molecule drugs for patients with serious diseases. The company has obtained approval for several products that treat forms of cystic fibr
3 Cheap Stocks to Buy That Are Crushing the Market
05:55am, Thursday, 23'rd Jun 2022
All three could continue their winning ways.
Where to Invest $10,000 in a Bear Market
06:30am, Wednesday, 22'nd Jun 2022
It's time to prepare your portfolio for long-term growth.
5 Stocks in S&P 500 ETF That Gained Last Week
11:39am, Monday, 20'th Jun 2022
The S&P 500 wrapped up its worst week since March 2020, tumbling 5.8%. Despite the massive decline, some of the stocks in SPY?
Strength Seen in Vertex (VRTX): Can Its 4.8% Jump Turn into More Strength?
10:06am, Monday, 20'th Jun 2022
Vertex (VRTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
